pCMV-PEmax-P2A-GFP Citations (2)
Originally described in: Enhanced prime editing systems by manipulating cellular determinants of editing outcomes.Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen PF, Chen C, Nelson JW, Newby GA, Sahin M, Osborn MJ, Weissman JS, Adamson B, Liu DR Cell. 2021 Oct 28;184(22):5635-5652.e29. doi: 10.1016/j.cell.2021.09.018. PubMed Journal
Articles Citing pCMV-PEmax-P2A-GFP
Articles |
---|
Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene. Hasan MN, Hyodo T, Biswas M, Rahman ML, Mihara Y, Karnan S, Ota A, Tsuzuki S, Hosokawa Y, Konishi H. PLoS One. 2023 Nov 9;18(11):e0294146. doi: 10.1371/journal.pone.0294146. eCollection 2023. PubMed |
Prime-Editing of human ACTB in induced pluripotent stem cells to model human ACTB Loss-of-Function diseases and compensatory mechanisms. Binder S, Ramachandran H, Hildebrandt B, Dobner J, Rossi A. Stem Cell Res. 2024 Mar;75:103304. doi: 10.1016/j.scr.2024.103304. Epub 2024 Jan 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.